Dacomitinib: an investigational drug for the treatment of glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dacomitinib: an investigational drug for the treatment of glioblastoma

Published:2018-10-03 Issue:10 Volume:27 Page:823-829
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Sepúlveda Juan Manuel¹^ORCID,Sánchez-Gómez Pilar²^ORCID,Vaz Salgado María Ángeles³,Gargini Ricardo⁴,Balañá Carmen⁵

Affiliation:

1. Neurooncology Unit, Hospital Universitario 12 de Octubre, Madrid, Spain

2. Neurooncology Unit, Instituto de Salud Carlos III, UFIEC, Madrid, Spain

3. Servicio de Oncología Médica, Hospital Universitario Ramón y Cajal, Madrid, Spain

4. Molecular neuropathology, Centro de Biología Molecular, CSIC, Madrid, Spain

5. Neurooncology and Sarcomas, Catalan Institute of Oncology (ICO) Badalona, Barcelona, Spain

Funder

RG

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2018.1528225

Reference39 articles.

1. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

2. The sequential use of carmustine wafers (Gliadel®) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review

3. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma

4. The Somatic Genomic Landscape of Glioblastoma

5. Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Visualization of Brain Tumors with Infrared-Labeled Aptamers for Fluorescence-Guided Surgery;Journal of the American Chemical Society;2024-08-26

2. Exploring ncRNA-mediated regulation of EGFR signalling in glioblastoma: From mechanisms to therapeutics;Life Sciences;2024-05

3. Glioblastoma Therapy: Past, Present and Future;International Journal of Molecular Sciences;2024-02-21

4. Comprehensive Molecular Genetic Analysis in Glioma Patients by Next Generation Sequencing;Brain Tumor Research and Treatment;2024

5. Development of novel green and high-throughput microwell spectrophotometric assay for one-step determination of dacomitinib, a recently approved potent drug for first-line treatment of metastatic non-small cell lung cancer;Sustainable Chemistry and Pharmacy;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3